Development of potent and proteolytically stable human neuromedin U receptor agonists
An De Prins(Vrije Universiteit Brussel), Steven Ballet(Vrije Universiteit Brussel), Mette M. Rosenkilde(University of Copenhagen), Dirk Tourwé(Vrije Universiteit Brussel), Yannick Van Wanseele(Vrije Universiteit Brussel), Ann Van Eeckhaut(Vrije Universiteit Brussel), Csaba Tömböly(HUN-REN Szegedi Biológiai Kutatóközpont), Vicky Caveliers(Universitair Ziekenhuis Brussel), Louise J. Skov(Laboratory of Molecular Genetics), Charlotte Martin(Vrije Universiteit Brussel), Ilse Smolders(Vrije Universiteit Brussel), Birgitte Holst(University of Copenhagen)
Cited by 20
Related Papers
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Agonists and Inverse Agonists for the Herpesvirus 8-encoded Constitutively Active Seven-transmembrane Oncogene Product, ORF-74
|Journal of Biological Chemistry|1999|185
Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
|BMC Pharmacology and Toxicology|2016|179
In Vivo Characterization of High Basal Signaling from the Ghrelin Receptor
|Endocrinology|2009|121